Top

Journal of Public Health

Published in:

01-08-2021 | Insulins | Original Article

Perceived impact of diabetes management in patients with cancer: the experience of a tertiary referral center

Authors: Alice Nervo, Alessandra Celeste Fracchia, Alberto Ragni, Valentina D’Angelo, Emanuela Arvat, Marco Gallo

Published in: Journal of Public Health | Issue 4/2021

Abstract

Aim

Diabetes management in patients with cancer has critical aspects. This study aims to assess the quality of life (QoL) and self-perceived impact of the management of diabetes on the overall situation of a group of subjects referred to a center dedicated to the management of diabetes in the oncological setting.

Subjects and methods

The study evaluated a sample of 23 consecutive cancer patients with diabetes referred to a tertiary hospital between June and December 2017. All patients were asked to fill in a dedicated questionnaire with 11 items assessing the improvement of typical symptoms of glycemic imbalance after starting anti-diabetic therapy, impact of diabetes self-management on their global situation, improvement of their self-perceived QoL, and perceived utility of a dedicated center for the integrated management between oncologists and endocrinologists.

Results

The responses to the questionnaire showed a partial/high improvement of all symptoms, especially in patients suffering from fatigue (68%), decreased appetite (78%), or reduced overall well-being (78%). In 26% of patients, diabetes self-management had a considerable impact on daily routine. However, a notable improvement of the QoL was reported in 74% of cases, despite the higher commitment due to self-monitoring of blood glucose and to insulin therapy. All of the patients reported the perceived utility of a dedicated center for the integrated management between oncologists and endocrinologists.

Conclusion

Diabetes management in patients with cancer is often complicated. A well-structured and individualized educational program may reduce the impact of diabetes on the patient’s daily routine and improve QoL.

American Diabetes Association (2019) Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care 42(Suppl 1):S13–S28. https://doi.org/10.2337/dc19-S002CrossRef

Balkau B (2000) The DECODE study. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. Diabetes Metab 26:282–286PubMed

Ballotari P, Vicentini M, Manicardi V, Gallo M, Chiatamone Ranieri S, Greci M, Giorgi Rossi P (2017) Diabetes and risk of cancer incidence: results from a population-based cohort study in northern Italy. BMC Cancer 17:703. https://doi.org/10.1186/s12885-017-3696-4CrossRefPubMedPubMedCentral

Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, Wolff AC, Brancati FL (2010) Postoperative mortality in cancer patients with preexisting diabetes: systematic review and meta-analysis. Diabetes Care 33:931–939. https://doi.org/10.2337/dc09-1721CrossRefPubMedPubMedCentral

Bonomo K, De Salve A, Fiora E, Mularoni E, Massucco P, Poy P, Pomero A, Cavalot F, Anfossi G, Trovati M (2010) Evaluation of a simple policy for pre- and post-prandial blood glucose self-monitoring in people with type 2 diabetes not on insulin. Diabetes Res Clin Pract 87:246–251. https://doi.org/10.1016/j.diabres.2009.10.021CrossRefPubMed

Bosi E, Scavini M, Ceriello A, Cucinotta D, Tiengo A, Marino R, Bonizzoni E, Giorgino F on behalf of the PRISMA Study Group (2013) Intensive structured self-monitoring of blood glucose and glycemic control in noninsulin-treated type 2 diabetes: the PRISMA randomized trial. Diabetes Care 36:2887–2894. https://doi.org/10.2337/dc13-0092CrossRefPubMedPubMedCentral

Bowker SL, Pohar SL, Johnson JA (2006) A cross-sectional study of health-related quality of life deficits in individuals with comorbid diabetes and cancer. Health Qual Life Outcomes 4:17CrossRef

Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R (1998) The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the AD-DQoL. Qual Life Res 8:79–91CrossRef

Camps C, del Pozo N, Blasco A, Blasco P, Sirera R (2009) Importance of quality of life in patients with non-small-cell lung cancer. Clin Lung Cancer 10:83–90. https://doi.org/10.3816/CLC.2009.n.010CrossRefPubMed

Carstensen B, Read SH, Friis S, Sund R, Keskimäki I, Svensson AM, Ljung R, Wild SH, Kerssens JJ, Harding JL, Magliano DJ, Gudbjörnsdottir S (2016) Diabetes and cancer research consortium. Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals. Diabetologia 59:980–988. https://doi.org/10.1007/s00125-016-3884-9CrossRefPubMedPubMedCentral

Clemente G, Giorgini M, Mancini M, Gallo M on behalf of the AMD-Associazione Medici Diabetologi ‘Diabetes and Cancer’ working group (2018) Diabetologists and oncologists attitudes towards treating diabetes in the oncologic patient: insights from an exploratory survey. Diabetes Res Clin Pract 143:420–427. https://doi.org/10.1016/j.diabres.2018.02.044CrossRefPubMed

EuroQol EQ-5D (n.d.) https://euroqol.org/. Accessed October 2019

Färkkilä N, Sintonen H, Saarto T, Järvinen H, Hänninen J, Taari K, Roine RP (2013) Health-related quality of life in colorectal cancer. Color Dis 15:e215–e222. https://doi.org/10.1111/codi.12143CrossRef

Fedeli U, Zoppini G, Gennaro N, Saugo M (2014) Diabetes and cancer mortality: a multifaceted association. Diabetes Res Clin Pract 106:e86–e89. https://doi.org/10.1016/j.diabres.2014.09.027CrossRefPubMed

Ford-Dunn S, Smith A, Quin J (2006) Management of diabetes during the last days of life: attitudes of consultant diabetologists and consultant palliative care physicians in the UK. Palliat Med 20:197–203CrossRef

Franciosi M, Lucisano G, Pellegrini F, Cantarello A, Consoli A, Cucco L, Ghidelli R, Sartore G, Sciangula L, Nicolucci A in behalf of the ROSES Study Group (2011) ROSES: role of self-monitoring of blood glucose and intensive education in patients with type 2 diabetes not receiving insulin. A pilot randomized clinical trial. Diabet Med 28:789–796. https://doi.org/10.1111/j.1464-5491.2011.03268.xCrossRefPubMed

Gallo M, Gentile L, Arvat E, Bertetto O, Clemente G (2016) Diabetology and oncology meet in a network model: union is strength. Acta Diabetol 53:515–524. https://doi.org/10.1007/s00592-016-0839-zCrossRefPubMed

Gallo M, Muscogiuri G, Felicetti F, Faggiano A, Trimarchi F, Arvat E, Vigneri R, Colao A (2018) Adverse glycaemic effects of cancer therapy: indications for a rational approach to cancer patients with diabetes. Metabolism 78:141–154. https://doi.org/10.1016/j.metabol.2017.09.013CrossRefPubMed

Hershey DS, Given B, Given C, Von Eye A, You M (2012) Diabetes and cancer: impact on health-related quality of life. Oncol Nurs Forum 39:449–457. https://doi.org/10.1188/12.ONF.449-457CrossRefPubMed

Hirsch A, Bartholomae C, Volmer T (2000) Dimensions of quality of life in people with non-insulin dependent diabetes. Qual Life Res 9:207–218CrossRef

Holmes J, McGill S, Kind P, Bottomley J, Gillam S, Murphy M (2000) Health-related quality of life in type 2 diabetes (TARDIS-2). Value Health 3(Suppl 1):47–51CrossRef

Huang Y, Cai X, Qiu M, Chen P, Tang H, Hu Y, Huang Y (2014) Prediabetes and the risk of cancer: a meta-analysis. Diabetologia. 57:2261–2269. https://doi.org/10.1007/s00125-014-3361-2CrossRefPubMed

International Diabetes Federation (2017) IDF Diabetes Atlas, 8th edn., Brussels

Jacob P, Chowdhury TA (2015) Management of diabetes in patients with cancer. QJM 108:443–448. https://doi.org/10.1093/qjmed/hcu218CrossRefPubMed

King EJ, Haboubi H, Evans D, Baker I, Bain SC, Stephens JW (2012) The management of diabetes in terminal illness related to cancer. QJM 105:3–9. https://doi.org/10.1093/qjmed/hcr167CrossRefPubMed

Latini DM, Chan JM, Cowan JE, Arredondo SA, Kane CJ, Penson DF, DuChane J, Carroll PR on behalf of the CaPSURE investigators (2006) Health-related quality of life for men with prostate cancer and diabetes: a longitudinal analysis from CaPSURE. Urology 68:1242–1247CrossRef

Leak A, Davis ED, Houchin LB, Mabrey M (2009) Diabetes management and self-care education for hospitalized patients with cancer. Clin J Oncol Nurs 13:205–210. https://doi.org/10.1188/09.CJON.205-210CrossRefPubMedPubMedCentral

Lee W, Yoon YS, Han HS, Cho JY, Choi Y, Jang JY, Choi H (2016) Prognostic relevance of preoperative diabetes mellitus and the degree of hyperglycemia on the outcomes of resected pancreatic ductal adenocarcinoma. J Surg Oncol 113:203–208. https://doi.org/10.1002/jso.24133CrossRefPubMed

Maddigan SL, Feeny DH, Johnson JA (2005) Health-related quality of life deficits associated with diabetes and comorbidities in a Canadian National Population Health Survey. Qual Life Res 14:1311–1320CrossRef

Mateo J, Castro F, Olmos D on behalf of the European Society for Medical Oncology (2013) Cancer treatment in patients with diabetes. In: 2013 ESMO handbook on cancer treatment in special clinical situations. ESMO Press, pp 72–88

McCoubrie R, Jeffrey D, Paton C, Dawes L (2005) Managing diabetes mellitus in patients with advanced cancer: a case note audit and guidelines. Eur J Cancer Care (Engl) 14:244–248CrossRef

Mols F, Aquarius AE, Essink-Bot ML, Aaronson NK, Kil PJ, van de Poll-Franse LV (2008) Does diabetes mellitus as a comorbid condition affect the health-related quality of life in prostate cancer survivors? Results of a population-based observational study. BJU Int 102:1594–1600. https://doi.org/10.1111/j.1464-410X.2008.07812.xCrossRefPubMed

National Cancer Institute (n.d.) Common terminology criteria for adverse events (CTCAE) version 4.03. https://www.eortc.be/services/doc/ctc/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf. Accessed February 2019

Nicolucci A, Kovacs Burns K, Holt RI, Comaschi M, Hermanns N, Ishii H, Kokoszka A, Pouwer F, Skovlund SE, Stuckey H, Tarkun I, Vallis M, Wens J, Peyrot M on behalf of the DAWN2 Study Group (2013) Diabetes attitudes, wishes and needs second study (DAWN2™): cross-national benchmarking of diabetes-related psychosocial outcomes for people with diabetes. Diabet Med 30:767–777. https://doi.org/10.1111/dme.12245CrossRefPubMed

Onitilo AA, Donald M, Stankowski RV, Engel JM, Williams G, Doi SA (2013) Breast and prostate cancer survivors in a diabetic cohort: results from the living with diabetes study. Clin Med Res 11:210–218. https://doi.org/10.3121/cmr.2013.1156CrossRefPubMedPubMedCentral

Polonsky WH, Fisher L, Schikman CH, Hinnen DA, Parkin CG, Jelsovsky Z, Petersen B, Schweitzer M, Wagner RS (2011) Structured self-monitoring of blood glucose significantly reduces A1c levels in poorly controlled, non insulin treated type 2 diabetes: results from the structured testing program study. Diabetes Care 34:262–267. https://doi.org/10.2337/dc10-1732CrossRefPubMedPubMedCentral

Psarakis HM (2006) Clinical challenges in caring for patients with diabetes and cancer. Diabetes Spectr 19:157–162. https://doi.org/10.2337/diaspect.19.3.157CrossRef

Quality of Life Group Website (n.d.) https://qol.eortc.org/. Accessed October 2019

Ranc K, Jørgensen ME, Friis S, Carstensen B (2014) Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment. Diabetologia 57:927–934. https://doi.org/10.1007/s00125-014-3186-zCrossRefPubMed

Rete Oncologica Piemonte-Valle d’Aosta (2018) Protocollo per la gestione del paziente oncologico con diabete mellito. http://www.reteoncologica.it/area-operatori/terapie-di-supporto/raccomandazioni-terapie-di-supporto. Accessed February 2019

Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, Lin X, Greenfield TK, Litwin MS, Saigal CS, Mahadevan A, Klein E, Kibel A, Pisters LL, Kuban D, Kaplan I, Wood D, Ciezki J, Shah N, Wei JT (2008) Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 358:1250–1261. https://doi.org/10.1056/NEJMoa074311CrossRefPubMed

Vissers PA, Thong MS, Pouwer F, den Oudsten BL, Nieuwenhuijzen GA, van de Poll-Franse LV (2014) The individual and combined effect of colorectal cancer and diabetes on health-related quality of life and sexual functioning: results from the PROFILES registry. Support Care Cancer 22:3071–3079. https://doi.org/10.1007/s00520-014-2292-2CrossRefPubMed

Zendehdel K, Nyrén O, Ostenson CG, Adami HO, Ekbom A, Ye W (2003) Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. J Natl Cancer Inst 95:1797–1800CrossRef

Title: Perceived impact of diabetes management in patients with cancer: the experience of a tertiary referral center
Authors: Alice Nervo
Alessandra Celeste Fracchia
Alberto Ragni
Valentina D’Angelo
Emanuela Arvat
Marco Gallo
Publication date: 01-08-2021
Publisher: Springer Berlin Heidelberg
Keywords: Insulins
Diabetes
Insulins
Published in: Journal of Public Health / Issue 4/2021
Print ISSN: 2198-1833
Electronic ISSN: 1613-2238
DOI: https://doi.org/10.1007/s10389-020-01200-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Perceived impact of diabetes management in patients with cancer: the experience of a tertiary referral center

Abstract

Aim

Subjects and methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Aim

Subjects and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2021

Perception of basic package of health services’ impact on health service delivery and mortality among residents of Wulu County, South Sudan

Uptake of intermittent preventive treatment in pregnancy for malaria: further analysis of the 2016 Ghana Malaria Indicator Survey

Analysis of risk and protective factors for psychosocial distress among in-school adolescents in Tanzania

Corporate social responsibility vs. financial interests: the case of responsible gambling programs

Turnover intention among service providers in Chinese methadone maintenance treatment clinics

Dyslipidemia and its associated factors in patients with type 2 diabetes mellitus